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Dr. Kathleen Faulkner is currently the Medical Director and a Hospice and Palliative Care Physician 
for the VNA Care Hospice and Palliative Medicine.  In her 50-year career in palliative and care, Dr. 
Faulkner has served in many leadership capacities, such as the Medical Director for other Hospice 
organizations, faculty for Harvard University and Tufts School of Medicine, reviewer for numerous 
academic journals, board member of many domestic and international palliative and hospice 
organizations, author of over 20 peer-reviewed articles and texts, as well as winner of dozens of 
excellence in leadership awards.  
 
Dr. Faulkner has consistently been a driver of change and was one of the first physicians certified in 
hospice and palliative medicine. Dr. Faulkner continues to contribute to the field of hospice and 
palliative care by giving frequent local and national lectures and authoring texts on clinical issues in 
hospice and palliative care.  
 
Interview Abstract  
Dr. Faulkner begins the interview by describing her early career experiences and how those shaped her 
journey into pediatric palliative care. She attributes a lot the success of her early career to her 
“nurturing environment” of like-minded clinicians. She then describes some of her experiences being a 
part of an early practice to make death a more natural and less isolated experience for the patient and 
family.  
 
Dr. Faulkner then how she helped to evolve end of life care to become more inclusive for families, 
while also supporting improved communications between providers and family decision makers. Dr. 
Faulkner became involved with Children’s Hospice International and worked to develop programming 
for home-based care and natural death without aggressive curative treatments at end of life.  
 
As Dr. Faulkner became more involved with hospice programming, she helped to develop best 
practices at the intersection of pediatrics and end of life care, and she also helped to integrate family 
support and family care into the health care plans of pediatric providers. Dr. Faulkner met some barriers 
such as providers not prescribing meaningful doses of pain and symptom management medicines to 
pediatrics as well as general lack of training of hospice staff in how to care for dying children.   
 
Dr. Faulkner concludes the interview by describing some of the successes she has seen over her career 
in the care of sick children and her vision for providers to work together to follow family care plans 
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Glossary of Acronyms  
Abbreviation Definition  
AAHPM American Academy of Hospice and 
Palliative Medicine 
ASCO American Society of Clinical 
Oncology 
CBC  Complete blood count  
CHI Children’s Hospice International 
E.T.  E.T. The Extra Terrestrial  
DNR Do not resuscitate order 
IV Intravenous  
LPs Lumbar punctures 
MS Contin Morphine sulfate controlled-release 
NAD Nicotinamide adenine dinucleotide 
NHO National Hospice Organization 
NP nurse practitioners 
OR Operating room 
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Bryan Sisk: Today is July 22, 2019. I am Bryan Sisk and I am in St Louis, Missouri 
interviewing Kathleen Faulkner over the telephone with the Pediatric Palliative 
Care Oral History project. Dr. Faulkner is in Dover, Massachusetts. Thank you 
Dr. Faulkner for joining me today. To get us started could you tell me when your 
mind turned towards pediatric palliative care as a career focus? 
 
Kathleen Faulkner: As a career focus. Well, I think initially I was interested in pediatric oncology 
and that was the career focus that I had. But in those days, which was back in the 
1970s, you couldn't be interested in oncology without being aware of death 
because we had just started being able to treat the various cancers that children 
had. So often it was palliative care although there was absolutely no term like 
that or no term like hospice. So when I started, I went to Kansas University 
Medical School from 1972 to '75. Leukemia was being treated successfully but 
they were just discovering that if you didn't treat the central nervous system then 
many, many of the children would eventually relapse with CNS disease and at 
that point, were basically uncurable. And also I remember that it was the very 
beginning that we treated the first patient with non-Hodgkin's lymphoma and that 
was such intensive chemotherapy for those days and we were so unskilled at 
giving it, that I am pretty sure that little boy was in the hospital for almost three 
months for his infection. So, it was very, very different time and place but from 
the very beginning I was exposed to a group of oncologists and others that really 
believed in this keen concept of treating patients and family.  
[00:02:20] 
Bryan Sisk: That's very interesting. That was a couple of years after Emil Freireich, but that 
was when the push really came "how can we create these kind of combinations 
and cocktails of chemotherapies?" And early on there was a lot of concern about 
toxicities, and like you mentioned, not knowing exactly what doses to give and 
how to manage them.   
 
Kathleen Faulkner: What was going on, right.  
[00:02:44] 
Bryan Sisk: How was that viewed by clinicians on the ground—with fear, with trepidation, 
with excitement? 
 
Kathleen Faulkner: So I think mostly it was excitement. I can clearly remember that part of my spiel 
was to tell families that, you know, what we were asking their children and them 
to go through—was really dramatic. It involved hair loss and lots of signs of 
critical illness. But that if they got through it, that they would then be cured.  
Because we had no idea of second cancers and no idea of long-term effects. So it 
was really kind of that "one and done" philosophy that I think filled us with hope 
and optimism frankly.  But even at the beginning I was like—I was in school, 
you know, medical school in Kansas as I mentioned, but that was—you think that 
would be a very backward place, a very conservative place and it just so 
happened that I was there as a medical student the very first day on the oncology 
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rotation I was assigned to sit with a patient who was dying—a child dying in the 
hospital, but really in a peaceful environment with the parents at the bedside.  
 
And I remember that was terrifying for me as a medical student. But it was really 
a team commitment at that time to have one of the team members physically 
present at every death for the duration—the whole vigil in fact, the oncology, 
peds oncology was actually that the interim acting head was a woman 
psychiatrist rather than an oncologist, because the two or three oncologists that 
were there, knew they were not very good at organization and Shirley Lansky 
had been helping them, you know, with the care of the families and the children. 
And in fact when I was there, published a paper on how much out of pocket 
expenses were caused by having a child with cancer. So it was a very nurturing 
environment and it was very committed to whole person care at the very 
beginning. The Kansas farmers from the rural communities knew how to take 
care of dying creatures, and they would want to take their child home if they 
could keep everything under control.  That was back in the days when we were 
taught that oral morphine didn't work, because nobody had dared to give a large 
enough dose to account for the "first pass" effect, so we used oral methadone, 
which was available as kind of a PRN drug.   
 
And that was really my first experiences, which then continued when I went out 
to Seattle first because it was a specific oncology fellowship, where again the 
hospital worked as a team and the families were taken care of as a whole unit 
along with their child.  And often, because Seattle serviced a four-state area and 
because I was often dealing with bone marrow transplants which were just 
starting, we were often dealing with children and families who lived far away. 
And if we weren't giving them active therapy, I can remember having 
conferences, what would be called palliative care meetings now, with the child 
often, if they were old enough, with the family to really discuss their goals of 
care. So, I was lucky enough to be trained by people who were already joined on 
those concepts, and that made it easy.  
 
And then when I moved to Boston to continue with the research fellowship that's 
the first time I actually took, physically took care of children dying at home. I 
was assigned to a small, chronic out-patient—people that were just coming in, 
but by that time, second cancers had started to appear.  So, some of my kids were 
being treated. I started kind of, having a little bit more active clinical role, and 
that was the first time I actually got to go into houses, because there wasn't 
hospice at that point or certainly not hospice for children.  And so, the physicians 
would also kind of be there at the end and be the one providing the hands-on 
care. Later I felt lucky to have done that, but it was very stressful, at the time but 
fulfilling.   
[00:07:58] 
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Bryan Sisk: This working as a team in holistic care both at Kansas and at Seattle, did you get 
the impression that that was the norm or that you happened to land in exceptional 
places? 
 
Kathleen Faulkner: I think it was becoming more the norm. And so I think that was the time we were 
struggling with communication with children. I believe—I'm going to guess on 
the name, there was a psychologist I think, Gerald Koocher is what I remember 
but I could be wrong, who was looking at how the hospital staff reacted to a 
dying child. And this was happening when I was a fellow in Seattle because I 
remember reading about his results which were that, the closer the child came to 
dying, the less time the hospital staff spent with him or her and the farther they 
stood away from the bed. And I remember that we talked about it as fellows and 
decided that we would start timing ourselves and being aware of that. So that if 
children were dying in the hospital, we'd would make sure that we spend as much 
time with them as we did with children that were there that had medically urgent 
issues.  
 
So there was a lot of research going on, even at that time, and the struggle to 
have to include families and children. That was when children started to be 
included in the conversation. In Seattle I worked with a woman Patti Trull who 
was an occupational therapist on staff and part of the oncology team. She was a 
survivor, an early survivor of osteosarcoma with—she had a lung metastases and 
was one of the first to receive Adriamycin. She could remember that when she 
was going through treatment, she was never told she had cancer and all 
correspondence was sent by mail to her father's work address so that there would 
not be any possibility of her finding out what she was being treated for. She had 
radiation to her leg, but then she was told it was going to be amputated and that 
was if you lived long enough without metastatic disease, they were going to give 
you a chance of cure, but being prepared for the amputation, that was when they 
found out she had lung metastases. And she remembered being glad that she 
didn't have the surgery because she didn't understand why she was going to have 
her leg cut off at that point and no idea what the implications were.  But by the 
time I came along, that had really changed.  
 
So, I don't know if it was exceptional clinicians, but people were starting to think 
about it for sure and trying to respond in a different way because the kids were 
clearly upset by the lack of transparency.  
[00:11:28] 
Bryan Sisk: So, I'm really interested in talking about where kids were dying at that time. You 
were talking about maybe, the mid-70s to late 70s, that's around the time that Ida 
Martinson was doing her dying at home or her treatment at home project in 
Minnesota. So was that, again, was that something that you were doing before 
you became aware of that research or was that something that people commonly 
held, that kids could go home to— 
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Kathleen Faulkner: Could go home, yeah, that question was actually specifically what got me 
interested in pediatric hospice. So, I’m here in Massachusetts—I finish my 
fellowship. I went out to UMass to start the clinical portion of their new pediatric 
oncology program with a colleague from Children’s Hospital who was doing the 
research portion of it. And I got married, had a child and I was one year too early, 
that UMass didn’t have any nurse practitioners, and I happened to want to 
breastfeed, like physically breastfeed because the pumps were pretty primitive 
there, and it was too far away. There were NPs [nurse practitioners] in Seattle and 
there were NPs in the Midwest, but there weren’t NPs in the Boston area. They 
just weren't used then. So, I basically left that position. And during the time I 
took off with those two kids, I became a friend of the people who had been 
dealing with pediatric oncology consortium which was the Pediatric Oncology 
Group. The Pediatric Oncology Group had—they were members, and it was 
Brown, and Vermont and Mass General, and RI Hospital that had small 
programs. I actually looked at—there was a tiny research study looking at the 
percentage of the kids when asked whether they wanted to die home, actually got 
to do that and what percentage asked.   
 
As you would expect the vast majority of kids wanted to die at home. And most 
of the kids, except those with brain tumors, got to die at home. From these four 
places, which were again, not totally uncommon in my experience, but also in the 
forefront. So I presented that at, what I think was the first meeting of NHO 
[National Hospice Organization] and CHI [Children’s Hospice International], so 
the National Hospice Organization and Children's Hospice International had a 
joint meeting.  I remember being struck by how good the audience was. I had 
previously presented at ASCO [American Society of Clinical Oncology], my 
research project, so it wasn't too far in the past, and to say that was not a 
supportive audience would be understating the issue. It just did not—I mean 
loved to present but that was not a presentation with questions and answers; it 
was kind of like one lab fighting with another. I don't know, but it wasn't positive, 
and then I presented this at this meeting. And Chuck Corr, whom I didn't know 
from anyone, came out afterwards and said such supportive things, "We were 
really happy to have a physician who’s interested in this issue. If I can ever be of 
any assistance here's my card." People were so interested because they were 
interested in having clinical data. They were interested in the patient and the 
families, not necessarily their own careers.  Like Chuck didn't say to me, "I'm a 
famous person that has done a lot of research on this." No, he said, "Thank you 
for doing this. Can I help?" And that stuck with me. So, when I went back, I 
interviewed again at all the universities to see if I wanted to do oncology work, 
but people just did not seem happy, staff just didn't seem happy. In general, the 
people that I found in hospice were extraordinarily dedicated and passionate 
about their work. And so, I made the decision to switch and left university 
practice because of that. 
[00:16:16] 
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Bryan Sisk:  So, I want to talk a little more about pain management and other symptom 
control, because it sound like there was a lot of well-intentioned individuals but 
you had mentioned a little bit of the hesitance to give oral morphine in significant 
doses. What was the on the ground reality back in mid-70s of pain management?  
How effective was it, what were the barriers? What was it like? 
 
Kathleen Faulkner: It was, I would say fairly primitive. I think that the first handicap was that none 
of us really knew about oral medications.  So, if we had a chance, we would 
often use IV meds, it was a little hard.  In Seattle there was the bone marrow 
transplant. There was—you know Dr. Hickman was there. And so the Hickman 
Catheter actually came into existence during my training. He was a renal guy, but 
he had a lot of kids—he told me he needed to make money. [Laughter] So, that 
was the first kind of access where you could disconnect and be reconnected. For 
that some children that had a Hickman, you could teach the parents to administer 
medication IV, and that was actually done fairly often. We also used oral 
methadone without a whole lot of specific training.  It was really kind of trial, not 
too much error, I might say, but we were all learning. I had never seen a 
completely natural death in my training as a medical student or resident, because 
almost everyone who died got coded. There was no such thing as a DNR [Do not 
resuscitate order] initially.  
  
When I was at UMass we tried to do it. I tried to do with this one child whose 
mother didn't have a home that was set up large enough, there wasn't enough 
resources to care for him at home, but wanted to give this child with widely 
metastatic disease a comfortable death. And so by word of mouth, we asked him 
not be coded. And I remember driving home and getting paged, there were no 
cell phones then, so you'd get beepers, which were tremendous improvement and 
then you'd have to go find a pay phone. And then I found out that somehow the 
communication system has slipped and he was being—the child was being 
coded. And so, I ran back to the hospital. One of the nurses who knew the 
mother's intent basically, set up a curtain program like you would have in the OR 
[operating room], and she and the mom were at the head and they were playing 
his favorite music. Maybe from E.T., that was a very popular one in those days. 
And then they were doing the code through lines in the feet. Of course, they did 
manage to bring it back that day, but the residents rocked that child with mom, 
until he passed several days later. So natural death was almost unheard of. We all 
had to learn what symptoms were associated with it and what you could do. It 
was very primitive, but the parents were so grateful to have the child at home that 
often you got away with a little, maybe a less optimum treatment because you 
were there or you had presence with them on the phone.  
[00:20:27] 
Bryan Sisk: When you are talking about the pain, was this at a time where it was still largely 
treating pain as needed, or was this a time when transitioning towards 
anticipating pain? 
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Kathleen Faulkner: That's a good question. Not initially it was definitely as-needed. I think that's 
why we got away with using methadone the way that we did. Then somewhere in 
there, and I'm not going to be able—I may not be able to give you the decade, it 
became more routine. I can't remember when the MS Contin [morphine sulfate 
controlled-release] first became available. I think that was quite a bit later, but 
that was probably—by that time we had established you could use oral morphine 
and with the long acting form, then it was kind of a dosage thing but we lucked 
out a little bit because kids metabolisms were so good that they actually handled, 
what I see taking care of adults now is a relatively high dose of opioids, very 
well.  I remember when the fentanyl patch came out, it was a blessing. It was 
wonderful to use, but it was difficult because you'd get the kids feeling well and 
they'd go outside playing then so much of the patches would slide off. There 
were definitely some issues. I think one thing we did is stop treatment sooner. 
There were a number of salvage therapies.  So when kids were ready to go home 
to die, so to speak, they actually had a fairly better quality of life than what they 
had right now, when they've been through three or four lines of therapy.  So they 
were able to do things like play, and go to Disney World, and all the other things 
kids like to do or did like to do.   
[00:22:36] 
Bryan Sisk: One thing I've heard quite a bit about is, the things that the kids were put through 
in the name of their treatment, whether it be from the medications themselves 
causing disease, mouth sores and other types of pain and discomfort, the disease 
itself causing a lot of other problems, and then also the pain from procedures that 
were insufficiently sedated or insufficiently given pain medication like bone 
marrow aspirates and LPs [lumbar punctures]. From an on ground perspective 
was that some the pain and discomfort wasn't recognized, or was it more so that 
it was just accepted as kind of, the nature of the game. What was the reality? 
 
Kathleen Faulkner: I think it was recognized—by the time I was in Seattle for my fellowship, we 
actually used hypnosis on the kids. That provided excellent coverage for 
procedures. But we were taught that. I was actually in charge of teaching him 
self-hypnosis to the hemophiliacs, because that was before the days of 
manufactured aid—you never wanted to use unless you absolutely had to, 
because if they became immune to it, then it was over. So I remember my job 
was to teach them how to stop their own bleeding. At least by the time I got to 
Seattle, which was probably '79, I think '79. I mean there was treatment, but the 
only other thing that was considered an option was actually surgery, not surgery 
but anesthesia. And it felt like that that would just take so much time, we would 
only do it for children that were inconsolable—if they were really, really tired.   
But then it would be—they would have to come in like the night before or very 
early the morning of. Most offices were the night before those days, and then 
they'd have it in the OR and then there would be this recovery afterward. So, it 
was considered that it took too big of a chunk out of the kids lives, but we paid a 
lot of attention to it. We weren't allowed to do a procedure unless you knew how 
to do it. It was a little tough, but we had the bone marrow transplant where to 
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teach fellows, because the person donating the marrow was under anesthesia and 
needed multiple aspirations to get it enough. So we tried really hard to do it, but 
we did it more with non-medical means. And that's what I did when we came to 
UMass and started that, and nobody else was interested in those days. So, I was 
the only one doing the clinical work with one highly trained person and using 
hypnosis or distraction. It worked amazingly well. I didn't have too many kids— 
they didn't have a bad experience, so they didn't get quite as afraid.   
[00:26:13] 
Bryan Sisk: Another thing that you mentioned was the shifting roles that parents were taking 
caring of their kids. So how did, when you started out how did the role and the 
involvement of parents evolve? When was it when you started and how did you 
see that change?  
 
Kathleen Faulkner: Well, I think the parents certainly be—they were never excluded from the 
discussion, but I think they were included more and more as those years went on.  
Even at the very beginning when I was in medical school and during my 
pediatric residency, we had those fold out chairs, sofas that allowed a parent to 
sleep in the room. All of the rooms were set up that way for all the pediatric 
patients, but the oncology room is where they got a little bit bigger ones and a 
little bit more comfortable. So, there was definitely some attention to that. The 
fathers often were the ones to get excluded, it was much more a mother and a 
father. We were in Kansas; we were unaware of diversity [laughs], and the 
fathers were often working. The mothers were often very involved and the 
grandparents were often taking care of the other kids. I think what we became 
aware of is first the father and then the siblings—that you really, really had to 
treat the entire family.  
 
I remember one case that stuck in my mind when we were treating a little girl.  
She got relapses, but really wasn't completely end stage. This was at UMass.  So, 
this would have been fairly late in the 80s. Her sister, actually her older sister, 
became pregnant and without it being recognized by the staff at the hospital or 
her parents. The first sign of it when she had her seizure from the eclampsia, and 
she came a hair's breath away from dying. I just remember being totally and 
completely appalled that we could have missed something like that. To me that 
was a game changer. We had to do better.  
 
So, I think people were starting to be more aware of that. So again, that's the 
1980s. But we definitely had family conferences and we definitely were aware—
I was taught to be aware of what we call "practicing". So, even at the first 
conference, you were asking the family and child to go through something very 
difficult, but it was worth it because there was this chance for cure. I was taught 
to say, "But there may come a time when that chance for cure isn't there and then 
we wouldn't necessarily ask so much of you and your child." So, we would talk 
to you about what's most important to the child and to you at that point. We were 
always setting the stage, because even on a good day it was maybe 50% cured 
Interviewer:  Bryan Sisk  July 22, 2019 





and 50% died. I don't know. I was just trained by people who were aware of that 
and that's how we always practiced.   
[00:30:11] 
Bryan Sisk: When you say that parents were engaged, and increasingly engaged, was that 
primarily in decision-making, or was that on the hands-on care, or was it across 
the spectrum? 
 
Kathleen Faulkner: I think it was across the spectrum. I think the big chance came in urging the 
parents to pay more attention to their child's wishes. That was often the sticking 
point, where the child was aware and because of the way they felt—totally 
understood death was near. Our work was often helping that child have a voice in 
the family spectrum of decision-making. We talked about things like open 
communication patterns in families and closed communication patterns with 
families. We were always trying to promote the open and not the closed. The 
parents were often, what I would say, overly involved in the medical aspects of 
the care. Many of them felt that they could control—if they knew the CBC 
[complete blood count] results and they knew the medical jargon and lingo, that, 
that would protect them and make sure that their child got good care, et cetera, et 
cetera, and to shift the focus to the important things. But even then, if you give a 
parent permission to be a parent, they would often take that and go with it. They 
were willing to give medications but they didn't necessarily become fixated on 
the meds at the expense of what they needed to do as a family.   
 
In my experience, crisis in most cases really brought out the best in families, 
rather than disaster. Although obviously sometimes families couldn't cope with it 
and ended up divorcing afterwards. Things that we wouldn't want to see—that we 
didn't want to see.  
[00:32:27] 
Bryan Sisk: When did you first become aware that the palliative care was a profession?  
When did that enter your mind as a career? 
 
Kathleen Faulkner: Well, I think after the conference presentation, that was when I was first aware 
that there was such a thing as hospice. Palliative care didn't exist. And I think 
except maybe, who was the guy in Canada? In Canada, hospice had a negative 
connotation. And there was one, maybe I'll think of it, he was an adult— 
[00:33:05] 
Bryan Sisk:  Balfour Mount? 
 
Kathleen Faulkner: Yeah, he liked palliative care. I think he, I'm pretty sure he was the first one to 
use that term, but that was really late in my language. It was hospice at that point.  
And so, I became more involved with Children's Hospice International, which 
was in many ways the leading organization at that time, promoting the peaceful 
death of children and death at home if that's what they wanted. They had an 
alliance with Helen House, I believe in England, that was I think it was maybe 
the first pediatric kind of in-patient hospice, and I started going to CHI 
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conferences very regularly. They were the ones who really, Ann Armstrong-
Dailey, really, really promoted the field, made it more visual. I think one of the 
contributions, if I've done any, for the pediatric hospice and palliative care 
movement is to gently steer it into the mainstream. There were many people who 
felt the children's care was so different, that it should be a separate entity from 
adult hospice care. I really tried—I tried for a while to actually have a job at just 
doing pediatric hospice. I was here in Boston. I tried through a grant from 
Children's Hospice International to see if we couldn't get a four-state coalition 
going that would promote pediatric hospice. We got the State of Massachusetts, 
the legislature, really interested in a pediatric hospice program, which they 
actually continue to fund to this day. But it is not exactly pediatric—I would say 
it's more pediatric palliative care, it's layered onto something else. There were a 
lot of pediatricians who just really were unaware of the adult hospice movement 
but felt instinctively that it probably would not serve children and their families 
well.  
 
But I just have the feeling that we'd never be able to get a critical mass for a 
homecare base without using hospice, and that we would deny kids and their 
families support from trained staff if we tried to isolate it. Even though there was 
no hospice benefit at that point. All of it was usually given for free by the 
hospices. So I kept, I think, just pushing that we stay in the eyes of the National 
Hospice movement as it evolved. It really makes me very proud and pleased to 
see Joanne Wolfe, head of AAHPM [American Academy of Hospice and 
Palliative Medicine] now is nice. I think that although there are unique 
differences, we need the strength of a larger movement to bring the pediatric 
voices to the fore.   
[00:36:55] 
Bryan Sisk: So, when you started your work with CHI, were you still practicing as an 
oncologist? 
 
Kathleen Faulkner: So I did not go back to practice as an oncologist, I switched to hospice. That was 
because of a random friend that I met at a conference. I was going to a symptom 
management conference at Memorial Sloan Kettering, and it was shortly before I 
was ready to return back to work. And I happened to meet a person, an internist, 
who was a hospice medical director, and he was just ready to go on a six-month 
leave. He was going to the hospices of England to study. There wasn't a lot of 
information in adult hospice at that point. Often it would involve this kind of 
travel to England to see how they did it, because they were ahead of us. And 
maybe one paperback book by Robert Enck had some useful information in it. 
He asked me to cover at the hospice as acting medical director when he was 
gone. I was absolutely terrified to be taking care of adults. [laughs]. 
 
The very first question that a nurse asked me, at my very first team meeting—it 
involved a patient who had difficulty falling asleep. They asked what I used 
asked what I used as a sleep aid. In my mind, my first thought was my own 
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children and how they breast fed, and thinking, "Well we don't use drugs." I was 
completely and totally at a loss. I had no idea what she was asking or what to 
answer, so I determined clearly [laughs]. But in those days no hospice medical 
director ever saw a patient. It was just, you just sat at team meetings and you 
would occasionally, rarely, get a call in between because the patient's physicians 
were the ones that were still actively involved. And so the only time I'd be called 
is if the physician refused to give a patient morphine at home, which we had 
happen even in the Boston area fairly routinely for the first decade or so when I 
was in hospice. They just, either didn't believe in it or didn't think that adults 
should die at home. So, I made the decision to switch to hospice medicine to 
retrain in adult medicine. There wasn't—there weren’t fellowships there, so I 
ended up going to every conference that I could and reading what two books 
were available at that time, and include the care of children and part of that 
practice. So that I tried to work and was generally successful—I tried to work in 
a hospice that had a strong interest in pediatrics and it was really quite fulfilling, 
you know, it was good, and that's what I've done ever since.  
[00:40:23] 
Bryan Sisk: So that was probably late-80s then when you came back and started to work in 
hospice? 
 
Kathleen Faulkner: I'd have to look at my CV, to tell you the truth. When you get old, your CV gets 
too long. [laughs] It was probably the 90s I would say, right? 
[00:40:44] 
Bryan Sisk: Yeah, actually, it looks like you came back in '93 and became acting medical 
director at Hospice of Cambridge.  
 
Kathleen Faulkner: Yeah. 
[00:40:54] 
Bryan Sisk:  So at that point, how open were hospices to caring for children? 
 
Kathleen Faulkner: With almost no knowledge and lot of just plain commitment. It was, even the 
way children died was different. I can remember being called by a nurse and we 
had a baby who was dying. And the nurse was describing all of these symptoms,  
what was happening, and what should we do. Even before I could kind of wrap 
my mind around it, in the first sentence or two she said, "Oh, the baby just 
passed." So I think we were learning that—also adults usually stop eating for a 
period of several weeks and then they die. Children would stay much more kind 
of metabolically active closer to death. And so, even the basic kind of signs and 
symptoms of death changed. We had to relearn that. It just took a lot of joint 
visits, a lot of phone calls, a lot of learning from every single patient that you 
took care of, in both adults and in pediatrics, to really build up the field. And it 
wasn't always perfect for the families. If it wasn't perfect, I would say, "I really, 
really learned from this experience, and I'll know what we can do little bit better 
next time. But I want you to know we tried as hard as we could and I think things 
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went very well," you know, something like that. And it was true. It was really 
individual-based learning.  
[00:42:59] 
Bryan Sisk: So thinking about pediatric palliative care, and you've talked a little bit about 
whether that should be hospice and palliative care for children, or pediatric 
palliative care as its own sub-discipline. What do you think was the spark the 
really drove the development of the focus on pediatrics, of the development of 
this discipline? 
 
Kathleen Faulkner: Well I don't think it was the pediatric hospitals. It could have been that pediatric 
hospitals promoted the home based care for children dying, but I didn't do that 
anymore than adult hospitals did until they were, really almost literally, forced.  I 
think we missed the opportunity for a continuum of care. I think here in Boston, 
for instance, I didn't have any direct contact with the board. But I knew Phil 
Pizzo when he was here for a while from Boston Children's was really— 
apparently, talked to the board about creating an out-patient based program that 
would include the continuum of home care and hospice. But the feedback I got 
was that they really didn't want to have the hospital associated with death. It had 
been the place that had discovered the treatment for Leukemia and they really 
didn't want to draw attention to "any failure", right. So that was upsetting. So, to 
me, I think the movement was driven mostly by people who were doing hospice 
work in the community, and those who were willing to consider caring for 
children. It was case by case, you know, some hospices would, and many 
hospices would not. It was also a very informal network.  
 
There was a time when I was getting random calls from people around the New 
England area, "We have this kid and we have them on this much," and they were 
all hospice nurses, that I even—you know Paul Thayer and I, who's a play 
therapist and social worker at one of the hospices that I worked with. We would 
really take the message of pediatric hospice out to the hospice conferences, the 
adult conferences. So our names were fairly well-known; and we get this call 
from some nurse in Vermont who wanted to know how to handle the symptoms 
of a child that was on service, and I gave it. You know, that, in today's medical 
legal [laughs], the atmosphere I don't think we would, just freely offer 
knowledge over the phone randomly. But there were so few people on those 
days, that we all just felt compelled to try and jointly care for every single child.  
It got better.  
[00:46:31] 
Bryan Sisk: How much do you think the adult hospice movement, Cicely Saunders, through 
the 60s and 70s, that I'm very sure you're familiar with. How much do you think 
that impacted the development of pediatric palliative care? 
 
Kathleen Faulkner: I think it definitely helped. I think it was—even in the stages of death. The 
hospice movement and Kübler-Ross' publications, they made the normal public 
aware of death. The fact that we were able to do resuscitation, that was relatively 
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new, to be able to resuscitate. So, it went from being able to do it, to having to do 
it. Even in times when it seemed kind of crazy, to this kind of anti-medical 
movement. So, I think it did help having adults who want to die at home, that 
allowed children to die at home. Because in order to die successfully at home you 
have to have people who can come to you. I tried to do it over the phone. We 
would do the best we can, but sometimes it's much better if you have a physician 
or a nurse, or a psychologist or someone who can actually support the family 
physically, be there and help them through it. And so, you needed people in the 
community that were willing to take care of dying people first, and then dying 
children.   
[00:48:18] 
Bryan Sisk: Do you think there were any negative influences or any barriers that having this 
robust adult movement had on the care of pediatric patients? 
 
Kathleen Faulkner: I'm not aware of that. I may not be thinking of something, but no, I don't think so. 
[00:48:47] 
Bryan Sisk: A couple of questions to wrap up. When you look over your career, and granted 
you mainly, you've run organizations that primarily provide care for adults but 
also provided a lot of care for children, what have been the biggest changes in the 
care that these kids suffering and dying from serious illnesses get? What are the 
biggest changes you've seen over your career? 
 
Kathleen Faulkner: Well I think the course of the children's illnesses has gotten to be quite a bit 
longer. As improvements in therapy and the development of alternative therapy, 
when the disease has relapsed and oncology or support of children with severe 
neurologic illness receive. So I think that children are often are more presented as 
having more chronic illness just as they do with adults—more chronic illness 
rather than acute illness. And now that does have an effect on the child and the 
family, a lot of it is good. They have achieved milestones, they've had the 
opportunity to live long enough to develop their personhood. But it also means 
that the family has lived with the illness for many years. And if the child does 
die, the adjustment is much more difficult then say when a baby would die, but it 
would be in the first weeks of life. So I think improving the survival has had 
obviously overall benefits, but it also makes it more consuming with the children 
and the family.  
[00:50:44] 
Bryan Sisk: And we touched on this earlier, what is your favorite contribution that you've 
made to this care? 
 
Kathleen Faulkner: I think what other things that it does help to be kind of a constant presence. So I 
think my enjoyment of teaching at conferences, developing curriculum, what I 
guess curricula would be the appropriate actual right word spreading the word 
and encouraging people in the same way that I was encouraged. I think that's 
something that I feel quite positive about. And I just have been lucky enough 
because I've been in the field for so long, that I cared for an amazing number of 
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incredible children and their families. So it's very, very reinforcing to do the 
work, when you do get to see good outcomes follow people. Now I'm in 
communication with people, the remaining family members of kids that I've 
cared for decades and decades ago. You can even see it them passing down to the 
next generation, the siblings. So, I think I have a much—it allows me to kind of 
see a lot more of that circle of life and death and how it can be a positive impact, 
as well as a devastating one.   
[00:52:20] 
Bryan Sisk: What do you think are the strongest areas in the field in the care of these kids 
right now? 
 
Kathleen Faulkner: The strongest areas? 
[00:52:29] 
Bryan Sisk: Yeah. What's the brightest light? Not the individuals, but the brightest light in the 
care that we are providing for these kids?  
 
Kathleen Faulkner: I think they improved the symptom management has got to be right up there.  We 
have medications to work with, we understand more how to use them. There are 
a constant fine tuning going on, so I would say that probably more sophistication 
in symptom management in both palliative care, especially palliative care and 
then hospice, seems probably the brightest light that I have seen.  
[00:53:13] 
Bryan Sisk:  What do you think of the biggest challenges you still face field? 
 
Kathleen Faulkner: Well I think luckily there, hopefully always be relatively few children dying 
compared to adults, and so it is with a small field that's very dispersed over the 
large geographic area that's the United States. So I think there will always be a 
challenge.  I think we will always have to work—those in the field, really have to 
work very hard to connect with one another, and to work together with the 
advance of science and the psychology of the movement.  
[00:54:01] 
Bryan Sisk: Then given that there's this very strong community-based hospice infrastructure, 
and there's also been this strong growing in-patient palliative care, specially 
structured in pediatrics. Has that that led to collaboration what has that led to 
confrontation? How has that relationship been in-patient development?   
 
Kathleen Faulkner: I think in my experience most of it has been collaboration, I think that when I see 
the conflict might be too strong what time, it often seems to arise from the 
parents who are quite willing to give up being in an academic world where they 
can reassure themselves that they are giving the absolute best the world has to 
offer to their children. But I think the actual participants in the field from all 
disciplines in my area at least really make a commitment to do with each other in 
a respectful manner that encourages completion of the family's care plan. It's 
impressive, actually.  
[00:55:29] 
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Bryan Sisk: And lastly, I would just love for you to dream aloud. If budget, politics, turf, and 
all the other things we were talking about were no obstacles, what do you want 
care for these kids to look like in 10 years?  
 
Kathleen Faulkner: I would like to continue to support the education and development of people in 
the community who feel comfortable and are competent in caring for children. I 
think many of the illnesses that children have are going to necessitate them going 
in much of the country, in going longer distances to receive treatment. And I 
would like all kids and their families to be very comfortable in going home and 
knowing that they are going to find sophisticated support in their home 
communities, if that's what they choose to do.  
[00:56:39] 
Bryan Sisk: Those are all of my questions. Is there any other aspect of this history did you 
think that I really missed out on that I should dig into further?   
 
Kathleen Faulkner: No, you are, I'm impressed. [laughs] Thank you for doing this. Like I said, Oh 
my god, I couldn't possibly do what you are doing. But you are very nice to be 
doing it. I think it's a good thing.  
 
Bryan Sisk: I hope so. I'm enjoying it. I'm certainly learning a lot. Hopefully a lot of other 
people will too.  
 
[End of Audio] 
